Dr. Bradley Flansbaum, who blogs on The Hospitalist Leader, is Director of Hospitalist Services at Lenox Hill Hospital in New York City. He’s also a keen observer of health care news coverage. He wrote the following guest post. He wrote to me, saying, “I treat a lot of pain, and always approach any claims re: Lidocaine patches with caution. The evidence is not strong. This piece is a lousy job for obvious reasons.”
——————————————————————————-
With greater focus on abuse of opioid analgesics the last few years, health care providers are seeking alternate means to treat pain. As a hospitalist, I have recently noticed an uptick of admitted patients wearing “pain patches,” and of more concern, a willingness on the part of trainees to prescribe them. It was with that in mind, that a recent USA Today piece caught my attention—not just for its misleading headline regarding patches, but also for its absence of heft to substantiate claims.
While the piece suggests there are a panoply of transdermal modalities to treat discomfort, only the lidocaine patch—cited as a treatment for fibromyalgia, has FDA approval and a “supporting” literature base, but only then for post-herpetic neuralgia. The Salonpas patch, an over-the-counter remedy, the other product mentioned and touted as an alternative means to relieve suffering, is devoid of such support. The company website highlights testimonials of success from both physician and non-physician providers, but peer-reviewed references are absent.
The implication of the article, which seems more a product promotion than an opportunity to inform, is that patches serve as mainstream alternatives to conventional treatments such as opioid and anti-inflammatory medications. That is not the case, and based on current knowledge regarding Lidocaine patches, practitioners’ need to take pause:
Potential off-label uses:
This is the Cochrane 2008 Review:
Insufficient evidence to recommend topical lidocaine as first-line treatment for postherpetic neuralgia
The story contained no data on effectiveness.
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like